Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice

BB AggarwalA BhardwajRS AggarwalNP SeeramS ShishodiaRole of resveratrol in prevention and therapy of cancer: preclinical and clinical studiesAnticancer Res2427832840200415517885

S BanerjeeC Bueso-RamosBB AggarwalSuppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclo-oxygenase 2, and matrix metalloproteinase 9Cancer Res6249454954200212208745

ZG LiT HongY ShimadaI KomotoA KawabeSuppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrolCarcinogenesis2315311536200210.1093/carcin/23.9.153112189197

EO LeeHJ LeeHS HwangKS AhnC ChaePotent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activitiesCarcinogenesis2720592069200610.1093/carcin/bgl05516675471

HS LiuCE PanW YangXM LiuAntitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c miceWorld J Gastroenterol914741476200312854144

L TessitoreA DavitI SarottoG CaderniResveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expressionCarcinogenesis2116191622200010.1093/carcin/21.8.161910910967

SC GuptaR KannappanS ReuterJH KimBB AggarwalChemosensitization of tumors by resveratrolAnn NY Acad Sci1215150160201110.1111/j.1749-6632.2010.05852.x21261654

D ColinE LimagneS JeanningrosA JacquelG LizardEndocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cellsCancer Prev Res410951106201110.1158/1940-6207.CAPR-10-027421467134

G LiS HeL ChangH LuH ZhangGADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrolPhytomedicine187047092011

M KartalG SaydamF SahinY BaranResveratrol triggers apoptosis through ceramide metabolizing genes in human K562 chronic myeloid leukemia cellsNutr Cancer63637644201110.1080/01635581.2011.53848521500096

S FaderlHM KantarjianM TalpazZ EstrovClinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemiaBlood913995401919989596644

MF GreavesJ WiemelsOrigins of chromosome translocations in childhood leukaemiaNat Rev3111200310.1038/nrc1164

J GreilM GramatzkiR BurgerR MarschalekM PeltnerThe acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7Br J Haematol86275283199410.1111/j.1365-2141.1994.tb04726.x8199015

RC StongSJ KorsmeyerJL ParkinDC ArthurJH KerseyHuman acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristicsBlood65213119853917311

B LangeM ValtieriD SantoliD CaraccioloF MavilioGrowth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell linesBlood7019219919873496132

G BaerschT MollersA HotteB Dockhorn-DworniczakC RubeGood engraftment of B-cell precursor ALL in NOD-SCID miceKlin Padiatr209178185199710.1055/s-2008-10439479293448

A BorgmannC BaldyA von StackelbergB BeyermannI FichtnerChildhood ALL blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID micePediatr Hematol Oncol17635650200010.1080/0888001005021134911127395

NLM LiemRA PapaCG MilrossMA SchmidM TajbakhshCharacterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapiesBlood10339053914200410.1182/blood-2003-08-291114764536

RB LockN LiemML FarnsworthCG MilrossC XueThe nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapseBlood9941004108200210.1182/blood.V99.11.4100

BA NijmeijerP MollevangerSL van Zelderen-BholaHC Kluin-NelemansR WillemzeMonitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID miceExp Hematol29322329200110.1016/S0301-472X(00)00669-X11274760

J DörrieH GerauerY WachterSJ ZuninoResveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cellsCancer Res6147314739200111406544

J DörrieK SapalaSJ ZuninoCarnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cellsCancer Lett1703339200111448532

C KellnerSJ ZuninoNitric oxide is synthesized in acute leukemia cells after exposure to phenolic antioxidants and initially protects against mitochondrial membrane depolarizationCancer Lett2154352200410.1016/j.canlet.2004.06.046

JB NachmanHN SatherMG SenselME TriggJM CherlowAugmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapyN Engl J Med33816631671199810.1056/NEJM1998060433823049614257

JA CrowellPJ KorytkoRL MorrisseyTD BoothBS LevineResveratrol-associated renal toxicityToxicol Sci82614619200410.1093/toxsci/kfh26315329443

SJ ZuninoDH StormsJM DucoreNovel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11)Cancer Lett2964954201010.1016/j.canlet.2010.03.01720381955

SJ ZuninoDH StormsJW NewmanTL PedersenCL KeenJM DucoreResveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse modelInt J Oncol4012771284201222200740

VA BrownKR PatelM ViskadurakiJA CrowellM PerloffRepeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisCancer Res7090039011201010.1158/0008-5472.CAN-10-236420935227

KR PatelE ScottVA BrownAJ GescherWP StewardClinical trials of resveratrolAnn NY Acad Sci1215161169201110.1111/j.1749-6632.2010.05853.x21261655

T WalleF HsiehMH De LeggeJE OatisUK WalleHigh absorption but very low bioavailability of oral resveratrol in humansDrug Metab Dispos3213771382200410.1124/dmd.104.00088515333514

X VitracA DesmouliereB BrouillaudS KrisaG DeffieuxDistribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administrationLife Sci72221922332003

E WenzelT SoldoH ErbersdoblerV SomozaBioactivity and metabolism of trans-resveratrol orally administered to Wistar ratsMol Nutr Food Res49482494200510.1002/mnfr.20050000315779067

JA BaurDA SinclairTherapeutic potential of resveratrol: the in vivo evidenceNat Rev Drug Discov5493506200610.1038/nrd206016732220

Y KimuraH OkudaResveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing miceJ Nutr13118441849200111385077

S BusquetsE AmetllerG FusterM OlivanV RaabResveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer modelCancer Lett245144148200710.1016/j.canlet.2005.12.03516466851

YL WengHF LiaoAF LiJC ChangRY ChiouOral administration of resveratrol in suppression of pulmonary metastasis of BALB/c mice challenged with CT26 colorectal adenocarcinoma cellsMol Nutr Food Res54259267201010.1002/mnfr.20090004919862773

SH KweonJH SongTS KimResveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via down-regulation of MRP1 expressionBiochem Biophys Res Commun395104110201010.1016/j.bbrc.2010.03.14720350534

KB HarikumarAB Kunnumakkara1G SethiP DiagaradjaneP AnandResveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancerInt J Cancer127257268201019908231